TE_38017
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluY |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 170.19 |
| Counts of samples | TCGA_tumor:150; TCGA_normal:0; GTEx:0 |
| TSS | chrX(-):94715418 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38017.11 | - | Intergenic | Non-coding | Non-coding | chrX(-):94697989,94698009,94702007,94704720,94715210,94715419 |
| teRNA_38017.12 | - | Intergenic | Non-coding | Non-coding | chrX(-):94702086,94702106,94715210,94715419 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
